BPG致力于知识的发现和传播
在F6Publishing中引用其的文章
For: Ramoni D, Liberale L, Montecucco F. Inflammatory biomarkers as cost-effective predictive tools in metabolic dysfunction-associated fatty liver disease. World J Gastroenterol 2024; 30(47): 5086-5091 [PMID: 39713167 DOI: 10.3748/wjg.v30.i47.5086]
URL: https://www.wjgnet.com/1009-3079/full/v30/i47/5086.htm
编号 Citing Articles
1
Gangfeng Zhu, Yipeng Song, Zenghong Lu, Qiang Yi, Rui Xu, Yi Xie, Shi Geng, Na Yang, Liangjian Zheng, Xiaofei Feng, Rui Zhu, Xiangcai Wang, Li Huang, Yi Xiang. Machine learning models for predicting metabolic dysfunction-associated steatotic liver disease prevalence using basic demographic and clinical characteristicsJournal of Translational Medicine 2025; 23(1) doi: 10.1186/s12967-025-06387-5
2
Marcin Kosmalski, Łukasz Mokros. Non-Alcoholic Fatty Liver Disease in Everyday Clinical Practice: From Diagnosis to TherapyLife 2025; 15(3): 363 doi: 10.3390/life15030363